China Jo-jo Drugstores Inc (CJJD)

$1.51

-0.14

(-8.41%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $1.51
    $1.67
    $1.51
    downward going graph

    0.0%

    Downside

    Day's Volatility :9.58%

    Upside

    9.58%

    downward going graph
  • $1.34
    $5.90
    $1.51
    downward going graph

    11.26%

    Downside

    52 Weeks Volatility :77.28%

    Upside

    74.4%

    downward going graph

Returns

PeriodChina Jo-jo Drugstores IncIndex (Russel 2000)
3 Months
-47.86%
0.0%
6 Months
-47.56%
0.0%
1 Year
-73.04%
0.0%
3 Years
-99.12%
-22.3%

Highlights

Market Capitalization
11.0M
Book Value
$8.97
Earnings Per Share (EPS)
-2.93
PEG Ratio
0.0
Wall Street Target Price
7.0
Profit Margin
-2.74%
Operating Margin TTM
-4.99%
Return On Assets TTM
-2.38%
Return On Equity TTM
-27.35%
Revenue TTM
154.5M
Revenue Per Share TTM
107.0
Quarterly Revenue Growth YOY
-0.2%
Gross Profit TTM
34.3M
EBITDA
-2.8M
Diluted Eps TTM
-2.93
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 363.58%

Current $1.51
Target $7.00

Company Financials

FY19Y/Y Change
Revenue
107.6M
↑ 11.9%
Net Income
-1.3M
↓ 92.28%
Net Profit Margin
-1.23%
↑ 16.52%
FY20Y/Y Change
Revenue
117.3M
↑ 9.09%
Net Income
-6.5M
↑ 390.05%
Net Profit Margin
-5.5%
↓ 4.27%
FY21Y/Y Change
Revenue
133.1M
↑ 13.47%
Net Income
-8.4M
↑ 29.7%
Net Profit Margin
-6.29%
↓ 0.79%
FY22Y/Y Change
Revenue
164.4M
↑ 23.48%
Net Income
-3.2M
↓ 61.81%
Net Profit Margin
-1.95%
↑ 4.34%
FY23Y/Y Change
Revenue
148.8M
↓ 9.48%
Net Income
-21.1M
↑ 560.92%
Net Profit Margin
-14.21%
↓ 12.26%
FY24Y/Y Change
Revenue
154.5M
↑ 3.85%
Net Income
-4.2M
↓ 79.97%
Net Profit Margin
-2.74%
↑ 11.47%
Q2 FY22Q/Q Change
Revenue
62.3M
-
Net Income
4.8M
-
Net Profit Margin
7.68%
-
Q4 FY22Q/Q Change
Revenue
72.7M
-
Net Income
-594.8K
-
Net Profit Margin
-0.82%
-
Q1 FY23Q/Q Change
Revenue
39.3M
↓ 45.98%
Net Income
-462.1K
↓ 22.3%
Net Profit Margin
-1.18%
↓ 0.36%
Q4 FY23Q/Q Change
Revenue
39.3M
↑ 0.0%
Net Income
-462.1K
↑ 0.0%
Net Profit Margin
-1.18%
↑ 0.0%
Q2 FY24Q/Q Change
Revenue
38.0M
↓ 3.32%
Net Income
-1.7M
↑ 258.13%
Net Profit Margin
-4.36%
↓ 3.18%
FY19Y/Y Change
Total Assets
72.7M
↓ 1.47%
Total Liabilities
55.8M
↑ 1.47%
FY20Y/Y Change
Total Assets
99.5M
↑ 36.83%
Total Liabilities
80.7M
↑ 44.8%
FY21Y/Y Change
Total Assets
106.3M
↑ 6.83%
Total Liabilities
81.9M
↑ 1.45%
FY22Y/Y Change
Total Assets
106.4M
↑ 0.07%
Total Liabilities
83.6M
↑ 2.12%
FY23Y/Y Change
Total Assets
91.0M
↓ 14.49%
Total Liabilities
74.3M
↓ 11.17%
FY24Y/Y Change
Total Assets
95.1M
↑ 4.49%
Total Liabilities
80.8M
↑ 8.69%
Q4 FY22Q/Q Change
Total Assets
101.8M
↑ 0.0%
Total Liabilities
79.8M
↑ 0.0%
Q1 FY23Q/Q Change
Total Assets
94.8M
↓ 6.88%
Total Liabilities
77.2M
↓ 3.26%
Q3 FY23Q/Q Change
Total Assets
94.8M
↑ 0.0%
Total Liabilities
77.2M
↑ 0.0%
Q4 FY23Q/Q Change
Total Assets
94.8M
↑ 0.0%
Total Liabilities
77.2M
↑ 0.0%
Q1 FY24Q/Q Change
Total Assets
95.1M
↑ 0.31%
Total Liabilities
80.8M
↑ 4.58%
Q2 FY24Q/Q Change
Total Assets
95.1M
↑ 0.0%
Total Liabilities
80.8M
↑ 0.0%
FY19Y/Y Change
Operating Cash Flow
-5.6M
↑ 170.68%
Investing Cash Flow
-7.3M
↑ 146.05%
Financing Cash Flow
8.1M
↓ 1147.89%
FY20Y/Y Change
Operating Cash Flow
-6.9M
↑ 23.29%
Investing Cash Flow
-4.8M
↓ 33.98%
Financing Cash Flow
19.0M
↑ 135.36%
FY21Y/Y Change
Operating Cash Flow
-62.3K
↓ 99.1%
Investing Cash Flow
-2.0M
↓ 58.68%
Financing Cash Flow
3.1M
↓ 83.8%
FY22Y/Y Change
Operating Cash Flow
-5.4M
↑ 8546.33%
Investing Cash Flow
-306.1K
↓ 84.68%
Financing Cash Flow
4.8M
↑ 57.05%
FY23Y/Y Change
Operating Cash Flow
-3.3M
↓ 39.04%
Investing Cash Flow
-316.1K
↑ 3.25%
Financing Cash Flow
2.4M
↓ 51.08%
Q2 FY22Q/Q Change
Operating Cash Flow
-10.8M
↑ 267.21%
Investing Cash Flow
-116.3K
↑ 93.79%
Financing Cash Flow
11.2M
↑ 1493.79%
Q3 FY22Q/Q Change
Operating Cash Flow
-2.2M
↓ 79.91%
Investing Cash Flow
-116.3K
↑ 0.0%
Financing Cash Flow
2.7M
↓ 76.18%
Q4 FY22Q/Q Change
Operating Cash Flow
-2.2M
↑ 0.0%
Investing Cash Flow
-116.3K
↑ 0.0%
Financing Cash Flow
2.7M
↑ 0.0%
Q1 FY23Q/Q Change
Operating Cash Flow
361.4K
↓ 116.65%
Investing Cash Flow
-116.3K
↑ 0.0%
Financing Cash Flow
164.0K
↓ 93.87%

Technicals Summary

Sell

Neutral

Buy

China Jo-jo Drugstores Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
China Jo-jo Drugstores Inc
China Jo-jo Drugstores Inc
-33.18%
-47.56%
-73.04%
-99.12%
-99.46%
Petmed Express Inc
Petmed Express Inc
4.11%
-34.33%
-69.93%
-88.24%
-79.93%
Trxade Health Inc
Trxade Health Inc
-5.58%
-66.16%
-42.49%
-91.61%
-93.41%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
-18.65%
-58.12%
-60.21%
-82.8%
-84.22%
High Tide Inc
High Tide Inc
14.62%
20.25%
23.27%
-73.83%
-78.22%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
China Jo-jo Drugstores Inc
China Jo-jo Drugstores Inc
NA
NA
0.0
0.0
-0.27
-0.02
NA
8.97
Petmed Express Inc
Petmed Express Inc
1191.0
NA
2.58
-0.19
-0.03
0.0
NA
4.56
Trxade Health Inc
Trxade Health Inc
NA
NA
NA
0.0
-2.69
-0.72
0.0
8.38
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
27.42
NA
3.55
2.57
-0.56
0.01
0.11
15.8
High Tide Inc
High Tide Inc
NA
NA
NA
-0.03
-0.23
0.02
NA
1.76
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
China Jo-jo Drugstores Inc
China Jo-jo Drugstores Inc
NA
$11.0M
-99.46%
NA
-2.74%
Petmed Express Inc
Petmed Express Inc
Sell
$69.6M
-79.93%
1191.0
-0.95%
Trxade Health Inc
Trxade Health Inc
Buy
$12.4M
-93.41%
NA
56.68%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Hold
$7.6B
-84.22%
27.42
-3.99%
High Tide Inc
High Tide Inc
Buy
$158.9M
-78.22%
NA
-6.82%

Insights on China Jo-jo Drugstores Inc

  • Vs HITI

    In the last 1 year, High Tide Inc has given 23.3% return, outperforming this stock by 96.3%

  • Vs HITI

    In the last 3 years, China Jo-jo Drugstores Inc has experienced a drawdown of -99.1%, however High Tide Inc resisted the overall trend and outperformed by 25.3%

Institutional Holdings

  • Hillhouse Capital Advisors, Ltd.

    0.30%

  • UBS Group AG

    0.03%

Company Information

Organization
China Jo-jo Drugstores Inc
Employees
939
CEO
Mr. Lei Liu M.D.
Industry
Retail Trade

Discover More

FAQs